Nuvation Bio Inc. Preferred Stock, Value, Issued
Nuvation Bio Inc. (NUVB) had Preferred Stock, Value, Issued of $274.94 million as of 2024-06-30, per its 10-Q filed 2024-08-05.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2024-08-05
- 2024-06-30: Preferred Stock, Value, Issued $274.94M.
- 2023-12-31: Preferred Stock, Value, Issued $0.00.
- 2020-12-31: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2024-06-30 | $274.94M 10-Q · filed 2024-08-05 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-05 |
| 2020-12-31 | $0.00 10-K/A · filed 2021-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |